作者
Angelo Pascarella,Lucia Manzo,Sara Gasparini,Oreste Marsico,Domenico Abelardo,Claudia Torino,Vittoria Cianci,Alfonso Iudice,Francesca Bisulli,Paolo Bonanni,Emanuele Caggia,Alfredo D'Aniello,Carlo Di Bonaventura,Jacopo C. DiFrancesco,Elisabetta Domina,Fedele Dono,Antonio Gambardella,Francesco Fortunato,Carla Marini,Alfonso Marrelli,Sara Matricardi,Alessandra Morano,Francesco Paladin,Rosaria Renna,Marta Piccioli,Pasquale Striano,Michele Ascoli,Angela La Neve,Emilio Le Piane,Alessandro Orsini,Gianfranco Di Gennaro,Umberto Aguglia,Edoardo Ferlazzo
摘要
Post-stroke epilepsy (PSE) is one of the most common causes of acquired epilepsy. Nevertheless, there is limited evidence regarding the clinical profile of antiseizure medications (ASMs) in PSE. This study aims to evaluate the 12-month effectiveness and tolerability of perampanel (PER) used as only add-on treatment in patients with PSE in a real-world setting.
加菲丰丰
shinysparrow
寻道图强
可口可乐了
乐乐乐乐乐乐
景辣条
精明元霜
mmyhn
sirius
AireenBeryl531
星辰大海
kento
morena
丘比特
浅尝离白
从容芮
樱桃猴子
共享精神
123木头人
鬼见愁
皖公网安备34019202002308
